Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David J Clark Insider Profile
4 Followers
David J Clark, CMO at Aldeyra Therapeutics, holds 17.88K shares in Aldeyra Therapeutics (Ticker: ALDX), holds ― shares in Trevi Therapeutics (Ticker: TRVI).
David J Clark has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David J Clark holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David J Clark
David J Clark's Trading History
Aldeyra Therapeutics
Sep 10, 2019
CMO
Uninformative Buy
25.30K
$69.01K
Trevi Therapeutics
―
CMO
―
―
List of latest transactions for each holding click on a transaction to see David J Clark's performance on stock
You May Also Like
David J Clark insider profile FAQ
What is the percentage of profitable transactions made by David J Clark?
The percentage of profitable transactions made by David J Clark is ―.
What is the average return per transaction made by David J Clark?
The average return per transaction made by David J Clark is ―.
What stocks does David J Clark hold?
David J Clark holds: ALDX, TRVI stocks.
What was David J Clark’s latest transaction?
David J Clark latest transaction was an Uninformative Buy of $25.30K.
What was David J Clark's most profitable transaction?
David J Clark’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David J Clark's role in Aldeyra Therapeutics?
David J Clark's role in Aldeyra Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.